BioRestorative Therapies (BRTX) Assets (2010 - 2025)
BioRestorative Therapies' (BRTX) quarterly Assets came in at $4.1 million in Q4 2025, down 66.78% YoY from $12.3 million in Q4 2024, and down 27.7% on a QoQ basis from $5.6 million in Q3 2025.
BioRestorative Therapies (BRTX) Assets (2010 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 16 years of Assets data on file, last reported at $4.1 million in Q4 2025.
- Quarterly Assets fell 66.78% year-over-year to $4.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.1 million (down 66.78% YoY) and the FY2025 annual result came in at $4.1 million, down 66.78% from the prior year.
- Assets slipped to $4.1 million in Q4 2025, from $5.6 million in the prior quarter.
- In the past five years, Assets ranged from a high of $22.5 million in Q4 2021 to a low of $2.2 million in Q3 2021.
- A 5-year average of $12.5 million and a median of $13.6 million in 2023 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets soared 723.9% — and 2025, when it tumbled 66.78%.
- Tracing BRTX's Assets over 5 years: stood at $22.5 million in 2021, then declined by 26.81% to $16.4 million in 2022, then retreated by 23.26% to $12.6 million in 2023, then fell by 2.63% to $12.3 million in 2024, then plunged by 66.78% to $4.1 million in 2025.
- The last three Assets figures came in at $4.1 million (Q4 2025), $5.6 million (Q3 2025), and $8.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | BioRestorative Therapies | 2.00 Mn | -953,752.60 | 17,964.00 | 4.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.08 Mn |
| Sep 30, 2025 | 5.64 Mn |
| Jun 30, 2025 | 8.52 Mn |
| Mar 31, 2025 | 10.33 Mn |
| Dec 31, 2024 | 12.28 Mn |
| Sep 30, 2024 | 14.57 Mn |
| Jun 30, 2024 | 16.12 Mn |
| Mar 31, 2024 | 17.95 Mn |
| Dec 31, 2023 | 12.61 Mn |
| Sep 30, 2023 | 13.80 Mn |
| Jun 30, 2023 | 13.30 Mn |
| Mar 31, 2023 | 14.08 Mn |
| Dec 31, 2022 | 16.43 Mn |
| Sep 30, 2022 | 17.92 Mn |
| Jun 30, 2022 | 19.44 Mn |
| Mar 31, 2022 | 20.92 Mn |
| Dec 31, 2021 | 22.45 Mn |
| Sep 30, 2021 | 2.18 Mn |
| Jun 30, 2021 | 2.88 Mn |
| Mar 31, 2021 | 3.70 Mn |